[1,2,4]TRIAZOLO[4,3-B][1,2,4]TRIAZINE COMPOUND, PREPARATION METHOD AND USE THEREOF
申请人:Shanghai Institute of Materia Medica,
Chinese Academy of Sciences
公开号:EP2650293A8
公开(公告)日:2013-12-25
The present invention relates to a structurally novel [1,2,4]triazolo[4,3-b][1,2,4]triazine compounds represented by formula (I) or formula (II), pharmaceutically acceptable salts thereof, prodrugs thereof, hydrates or solvates thereof, and also relates to a preparation method of the compounds, a pharmaceutical composition comprising a therapeutically effective amount of the compounds, as well as the use thereof as protein tyrosine kinase inhibitors, particularly as c-Met inhibitors, in the preparation of medicaments for the prevention and/or treatment of diseases associated with c-Met abnormality.
本发明涉及一种结构新颖的[1,2,4]三唑并[4,3-b][1,2,4]三嗪化合物,其由式(I)或式(II)表示,其药学上可接受的盐,其前药,其水合物或溶剂合物,还涉及该化合物的制备方法,包含所述化合物的治疗有效量的药物组合物,以及将其用作蛋白酪氨酸激酶抑制剂,特别是作为c-Met抑制剂,在制备与c-Met异常相关的疾病的药物中的使用。